Olivier Chesnoy
Chief Executive Officer at TECHNOFLEX
Profile
Olivier Chesnoy is currently the Chairman-Management Board at Technoflex SAS since 2011.
Prior to this, he was the Chairman & Chief Executive Officer at Theraptosis SA from 2009 to 2010.
Olivier Chesnoy active positions
Companies | Position | Start |
---|---|---|
TECHNOFLEX | Chief Executive Officer | 2011-09-07 |
Former positions of Olivier Chesnoy
Companies | Position | End |
---|---|---|
Theraptosis SA
Theraptosis SA Pharmaceuticals: MajorHealth Technology Theraptosis S.A. , a biotechnology company, was founded in April 2001. Theraptosis designs and develops various drugs that act on key apoptosis regulators to fight diseases associated with lack or excess of apoptosis including cancer and neurodegenerative diseases. The Company's key assets include a dual technology platform (CytoTrust™ and MitoTrust™) for screening and targeting purposes and a pipeline of products in the areas of CNS and oncology. Theraptosis' discovery engines integrate mitochondria, and apoptosis expertise, and has developed pre-clinical animal models. | Chairman | 2010-03-09 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Theraptosis SA
Theraptosis SA Pharmaceuticals: MajorHealth Technology Theraptosis S.A. , a biotechnology company, was founded in April 2001. Theraptosis designs and develops various drugs that act on key apoptosis regulators to fight diseases associated with lack or excess of apoptosis including cancer and neurodegenerative diseases. The Company's key assets include a dual technology platform (CytoTrust™ and MitoTrust™) for screening and targeting purposes and a pipeline of products in the areas of CNS and oncology. Theraptosis' discovery engines integrate mitochondria, and apoptosis expertise, and has developed pre-clinical animal models. | Health Technology |
Technoflex SAS
Technoflex SAS Chemicals: Major DiversifiedProcess Industries Technoflex SAS engages in the design, manufacture, and marketing of flexible containers for pharmaceutical industry. Its therapeutic applications include IV therapies, cell therapy, and biopharmaceuticals. The company's products include sterile bags, multi-chamber bags, and connectors. It also provides turnkey solutions and generic drug dossiers. The company was founded by Jacques Ponlot in 1972 and is headquartered in Bidart, France. | Process Industries |
- Stock Market
- Insiders
- Olivier Chesnoy